Impact of comorbidities and body mass index on the outcome of polycythemia vera patients-Reference-Cited by-同舟云学术

Impact of comorbidities and body mass index on the outcome of polycythemia vera patients

Published:2021-03-08 Issue:3 Volume:39 Page:409-418
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Benevolo Giulia¹,Elli Elena M.²,Bartoletti Daniela³⁴^ORCID,Latagliata Roberto⁵^ORCID,Tiribelli Mario⁶,Heidel Florian H.⁷,Cavazzini Francesco⁸,Bonifacio Massimiliano⁹^ORCID,Crugnola Monica¹⁰,Binotto Gianni¹¹,D'Addio Alessandra¹²,Tieghi Alessia¹³,Bergamaschi Micaela¹⁴,Caocci Giovanni¹⁵^ORCID,Polverelli Nicola¹⁶^ORCID,Bossi Elisa²,Auteri Giuseppe³⁴,Carmosino Ida⁵,Catani Lucia³,Cuneo Antonio⁸,Krampera Mauro⁹,Lanza Francesco¹²,Lemoli Roberto M.¹⁴¹⁷,Vianelli Nicola³,Breccia Massimo⁵^ORCID,Palumbo Giuseppe A.¹⁸,Cavo Michele³,Palandri Francesca³^ORCID

Affiliation:

1. Division of Hematology Città della Salute e della Scienza Hospital Torino Italy

2. Hematology Division San Gerardo Hospital ASST Monza Monza Italy

3. IRCCS Azienda Ospedaliero‐Universitaria di Bologna Istituto di Ematologia “Seràgnoli” Bologna Italy

4. Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna Bologna Italy

5. Division of Cellular Biotechnologies and Hematology University Sapienza Rome Italy

6. Division of Hematology and BMT Azienda Sanitaria Universitaria Integrata di Udine Italy

7. Department of Hematology and Oncology Friedrich‐Schiller‐University Medical Center Jena Germany

8. Division of Hematology University of Ferrara Ferrara Italy

9. Department of Hematology University of Verona Verona Italy

10. Division of Hematology Azienda Ospedaliero‐Universitaria di Parma Parma Italy

11. Unit of Hematology and Clinical Immunology University of Padova Padova Italy

12. Division of Hematology Onco‐Hematologic Department AUSL della Romagna Ravenna Italy

13. Department of Hematology Azienda USL ‐ IRCCS di Reggio Emilia Reggio Emilia Italy

14. Department of Internal Medicine (DiMI) Clinic of Hematology University of Genoa Genova Italy

15. Hematology Unit Department of Medical Sciences University of Cagliari Cagliari Italy

16. Unit of Blood Diseases and Stem Cell Transplantation ASST Spedali Civili di Brescia Brescia Italy

17. IRCCS Policlinico San Martino Genova Italy

18. Department of Scienze Mediche Chirurgiche e Tecnologie Avanzate “G.F. Ingrassia” University of Catania Catania Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2843

Reference38 articles.

1. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

2. Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IV

3. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

4. Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

5. Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis;Clinical and Experimental Medicine;2024-07-08

2. Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms;World Journal of Clinical Oncology;2024-06-24

3. Moving toward disease modification in polycythemia vera;Blood;2023-11-30

4. Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives;Annals of Hematology;2023-09-04

5. Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension;Annals of Hematology;2023-08-21